论文部分内容阅读
目的观察分析黄芪加胸腺5肽在肾综合征出血热(HFRS)治疗中的作用。方法对2003年1月~2004年12月在本院住院的HFRS患者150例分为3组进行观察。结果治疗组尿蛋白消失时间(4.12±2.53)天,尿素氮(BUN)复常时间(6.55±2.88)天,多尿期来临时间(3.45±1.55)天,感染出现2例,死亡3例,而对照组分别为(7.88±4.35)天,(9.01±2.99)天,(5.43±1.33)天,有明显差异(P<0.01)。结论黄芪加胸腺5肽治疗HFRS,可促进肾脏恢复,减少感染,缩短病程,降低病死率,提高疗效。
Objective To observe and analyze the role of Astragalus plus thymus 5 peptide in the treatment of hemorrhagic fever with renal syndrome (HFRS). Methods One hundred and fifty HFRS patients hospitalized in our hospital from January 2003 to December 2004 were divided into three groups and observed. Results The urinary albumin disappeared in the treatment group (4.12 ± 2.53 days), the duration of the normalization of urea nitrogen (BUN), the onset of polyuria (3.45 ± 1.55 days), the infection in 2 cases and the death in 3 cases While the control group were (7.88 ± 4.35) days, (9.01 ± 2.99) days, (5.43 ± 1.33) days, there was a significant difference (P <0.01). Conclusion Astragalus plus thymus 5 peptide treatment of HFRS, can promote kidney recovery, reduce infection, shorten the course of disease, reduce mortality and improve efficacy.